1361386-46-0

Basic information

• Product Name: 3-bromomethyl-5-tert-butylthiophene-2-carboxylic acid methyl ester
• Synonyms: 3-bromomethyl-5-tert-butylthiophene-2-carboxylic acid methyl ester
• CAS NO: 1361386-46-0
• Molecular Weight: 291.209
• Mol File: 1361386-46-0.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 345.5±42.0 °C(Predicted)
• Density: 1.367±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 3-bromomethyl-5-tert-butylthiophene-2-carboxylic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 3-bromomethyl-5-tert-butylthiophene-2-carboxylic acid methyl ester(1361386-46-0)
• EPA Substance Registry System: 3-bromomethyl-5-tert-butylthiophene-2-carboxylic acid methyl ester(1361386-46-0)

Safety Data

• Hazardous Substances Data: 1361386-46-0(Hazardous Substances Data)

Upstream product

• 23806-24-8 3-methyl-2-thiophenecarboxylic acid 
• 1361386-45-9 5-tert-butyl-3-methylthiophene-2-carboxylic acid methyl ester 
• 81452-54-2 methyl 3-methylthiophene-2-carboxylate 
• 61341-26-2 3-methylthenoyl chloride 

Downstream Products

• 1361386-47-1 methyl 3-{[(3-bromo-2-methylphenyl)amino]methyl}-5-(tert-butyl)thiophene-2-carboxylate 
• 1361386-48-2 3-{[(3-bromo-2-methylphenyl)amino]methyl}-5-(tert-butyl)thiophene-2-carboxylic acid 
• 1361386-49-3 5-(3-bromo-2-methylphenyl)-2-(tert-butyl)-4H-thieno[2,3-c]pyrrol-6(5H)-one 
• 1361386-50-6 2-(tert-butyl)-5-[2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4H-thieno[2,3-c]pyrrol-6(5H)-one 
• 1607005-71-9 3-[(4-bromo-2-fluorobenzylamino)methyl]-5-tert-butylthiophene-2-carboxylic acid methyl ester 
• 1610472-57-5 5-tert-butyl-3-({2-fluoro-4-[2-methoxy-6-(1-methyl-1H-pyrazol-4-yl)pyridin-4-yl]benzylamino}methyl)thiophene-2-carboxylic acid methyl ester 
• 1610472-59-7 2-tert-butyl-5-{2-fluoro-4-[2-methoxy-6-(1-methyl-1H-pyrazol-4-yl)pyridin-4-yl]benzyl}-4,5-dihydrothieno[2,3-c]pyrrol-6-one 
• 1610472-58-6 5-tert-butyl-3-({2-fluoro-4-[2-methoxy-6-(1-methyl-1H-pyrazol-4-yl)pyridin-4-yl]benzylamino}methyl)thiophene-2-carboxylic acid 
• 1610472-29-1 2-tert-butyl-5-{2-fluoro-4-[6-(1-methyl-1H-pyrazol-4-yl)-2-oxo-1,2-dihydro-pyridin-4-yl]-benzyl}-4,5-dihydro-thieno[2,3-c]pyrrol-6-one 
• 1361940-93-3 2-tert-butyl-5-(2-methyl-3-(4-methyl-6-(4-(4-methyl-3-oxopiperazin-2-yl)phenylamino)-5-oxo-4,5-dihydropyrazin-2-yl)phenyl)-4H-thieno[2,3-c]pyrrol-6(5H)-one 
• 1361940-92-2 tert-butyl 2-(4-(6-(3-(2-tert-butyl-6-oxo-4H-thieno[2,3-c]pyrrol-5(6H)-yl)-2-methylphenyl)-4-methyl-3-oxo-3,4-dihydropyrazin-2-ylamino)phenyl)-4-methyl-3-oxopiperazine-1-carboxylate 
• 1361941-11-8 2-bromo-6-(2-tert-butyl-6-oxo-4H-thieno[3,2-c]pyrrol-5(6H)-yl)benzyl acetate 
• 1361941-10-7 5-(3-bromo-2-(hydroxymethyl)phenyl)-2-tert-butyl-4H-thieno[3,2-c]pyrrol-6(5H)-one 
• 1361941-09-4 3-((3-Bromo-2-(hydroxymethyl)phenylamino)methyl)-5-tert-butylthiophene-2-carboxylic acid 

Relevant articles and documents

HETEROARYL COMPOUNDS AS BTK INHIBITORS AND USES THEREOF

The present invention relates to imidazo pyridine compounds, and pharmaceutically acceptable compositions thereof, useful as BTK inhibitors.

INHIBITORS OF BRUTON'S TYROSINE KINASE

This application discloses compounds according to generic Formula I: wherein all variables are defined as described herein, which inhibit Btk. The compounds disclosed herein are useful to modulate the activity of Btk and treat diseases associated with exc

PYRIDAZINONES, METHOD OF MAKING, AND METHOD OF USE THEREOF

Pyridazinone compounds of Formula (I) including stereoisomers, tautomers, and pharmaceutically acceptable salts thereof, useful for inhibiting Btk kinase, and for treating immune disorders such as inflammation mediated by Btk kinase. Methods of using compounds of Formula (I) for in vitro, in situ, and in vivo diagnosis, and treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.